Ignite Creation Date:
2024-05-06 @ 10:17 AM
Last Modification Date:
2024-10-26 @ 12:27 PM
Study NCT ID:
NCT03215693
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-08-16
First Post:
2017-07-11
Brief Title:
X-396 Capsule in Patients With ALK-positive Non-small Cell Lung Cancer Previously Treated With Crizotinib
Sponsor:
Betta Pharmaceuticals Co Ltd
Organization:
Betta Pharmaceuticals Co Ltd
Organization Data
Organization:
Betta Pharmaceuticals Co Ltd
Class:
INDUSTRY
Study ID:
BTP-42322
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Betta Pharmaceuticals Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None